Browsing: Pharma

With the long-awaited new approval of a daily pill, Johnson & Johnson and Protagonist Therapeutics…

As interest in the cancer-fighting potential of radiopharmaceuticals continues to grow, companies have made a…

More than 20 years after FDA approval of Flovent, GSK still dominates the U.S. asthma…

Building on years of significant investment from big pharmaceutical companies, Indiana is moving forward with…

The chance for Rhythm Pharmaceuticals’ Imshivly to break out of the genetic obesity realm is…

Moderna CEO Stéphane Bancel’s total compensation last year was surprisingly stable at $19.9 million, even…

About three weeks have passed since the war between the United States and Israel against…

Undersecretary Robert F. Kennedy Jr. introduced several high-profile changes to U.S. vaccine regulations and recommendations,…

BioMarin is focused on its CNP analog, Voxzogo, to write the next chapter of the…

The White House’s direct-to-consumer (DTC) platform TrumpRx is steadily expanding its catalog, with the latest…